{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:02:30Z","timestamp":1777417350640,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To identify the most appropriate dose of fluconazole for the treatment of symptomatic fungal urinary tract infection (UTI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>Primary literature identified through MEDLINE (1990\u2013June 2000). Key search terms included fluconazole and urinary tract infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>Fluconazole is approved for the treatment of candidal UTIs, but dosage recommendations are not consistent. An evaluation of clinical studies of fluconazole for the treatment of candidal UTI was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Questions remain about the optimal dosing of fluconazole, including the most appropriate dose in non-albicans species of candida as well as the optimal duration of therapy. Until further studies are performed, a fluconazole 200-mg loading dose followed by 100 mg\/d for at least four days appears to be the most appropriate dose for the treatment of symptomatic candidal UTI in patients without systemic fungal infection or severe renal failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.10170","type":"journal-article","created":{"date-parts":[[2003,6,3]],"date-time":"2003-06-03T17:09:48Z","timestamp":1054660188000},"page":"369-372","source":"Crossref","is-referenced-by-count":4,"title":["Fluconazole Dose Recommendation in Urinary Tract Infection"],"prefix":"10.1177","volume":"35","author":[{"given":"Kimi S","family":"Boedeker","sequence":"first","affiliation":[{"name":"Kimi S Boedeker PharmD, Internal Medicine Resident, College of Pharmacy, The University of Texas at Austin, Austin, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda J","family":"Kilzer","sequence":"additional","affiliation":[{"name":"Wanda J Kilzer PharmD BCPS, Assistant Professor, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2001,3,1]]},"reference":[{"key":"bibr1-aph.10170","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1993.tb02696.x"},{"key":"bibr2-aph.10170","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480200088030"},{"key":"bibr3-aph.10170","first-page":"2656","volume-title":"Principles and practice of infectious diseases","author":"Edwards EJ","year":"1995","edition":"4"},{"key":"bibr4-aph.10170","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.19.1929"},{"key":"bibr5-aph.10170","doi-asserted-by":"publisher","DOI":"10.1086\/313749"},{"key":"bibr6-aph.10170","doi-asserted-by":"publisher","DOI":"10.1086\/313580"},{"key":"bibr7-aph.10170","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401273300407"},{"key":"bibr8-aph.10170","volume-title":"Diflucan (fluconazole)","year":"1998"},{"key":"bibr9-aph.10170","first-page":"1463","volume-title":"Current medical diagnosis and treatment","author":"Hamill RJ","year":"2000","edition":"39"},{"key":"bibr10-aph.10170","first-page":"73","volume-title":"The Sanford guide to antimicrobial therapy 2000","author":"Gilbert DN","year":"2000","edition":"30"},{"key":"bibr11-aph.10170","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.5.1152"},{"key":"bibr12-aph.10170","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.1.30"},{"key":"bibr13-aph.10170","doi-asserted-by":"publisher","DOI":"10.1159\/000283074"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.10170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.10170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:04:33Z","timestamp":1777374273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.10170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1345\/aph.10170"],"URL":"https:\/\/doi.org\/10.1345\/aph.10170","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}